NCT04834154
Breast Cancer Type: HER2+, HR+ & HER2-negative, Triple Negative
Hormone Mutations: ER+, PR+
Other Mutations: 
Breast Cancer Tissue: 
Recruitment Status: Active, not recruiting
Not Applicable
Drug Category: Other

Key Eligibility Criteria:

Gender: All
Age: 18 Years and older (Adult, Older Adult)
Location of Metastases: 
Additional Notes: Breast cancer patients must be currently or within last 12 months in active treatment (surgery, chemotherapy, or radiation or on endocrine therapy); Patients must self identify as Spanish speaking & as Latinx/Latina/Latino
Exclusions: Patients who are not Spanish speaking
https://ClinicalTrials.gov/show/NCT04834154